Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Armenia Nazar

Armenia Nazar

Professor

Title: Blood pressure lowering effect of scopoletin on oxidative stress associated hypertensive rats

Biography

Biography: Armenia Nazar

Abstract

A blood pressure lowering effect of scopoletin on anesthetized oxidative stress associated hypertensive rats has been studied. Scopoletin (10 mg/kg BW) was given to the prednison-NaCl (PN) and prednison-NaCl-L-NAME (PNL) induced rats. As comparisons, other groups of the same rats were treated with Tempol (17.2mg/kgBW) and saline.  The direct animal carotid artery SBP, DBP, MAP and HR were measured (Biopac Acquisition System MP150) before and every half an hour for two hours after drug commencement. Plasma NO was measured before and at the end of the experiment.  Data of BPs and HR were analyzed using three-way ANOVA, while plasma NO was analyzed by two-way ANOVA followed by Tukey’s HSD-test (significance was taken at p<0.05).  Results showed that the animals SBP, DBP, and the MAP were significantly (p<0.05) reduced by scopoletin and tempol without any significant changed (p>0.1) in the animal HR.  The response of PNL hypertensive animals to scopoletin was greater and so the effect of scopoletin compare to tempol. Plasma NO of scopoletin and tempol treated rats also increased, but there was no significant different of average plasma NO between both hypertensive types. These indicated that scopoletin at the given dose is effective as blood pressure lowering agent, especially on the stress oxidative associated   hypertensive rats.